Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma
Marwah Al-Aloosi(Precision for Medicine (United States)), Carla Grandori(Precision for Medicine (United States)), Lauren Appleyard(Precision for Medicine (United States)), Alex Rajewski(Precision for Medicine (United States)), Payel Chatterjee(Precision for Medicine (United States)), Rachele Rosati(Precision for Medicine (United States)), Brady Bernard(Providence Portland Medical Center), Eva J. Gordon, Christopher J. Kemp(Fred Hutch Cancer Center), Robert L. Diaz, Amber McDonald, Shalini Pereira(Precision for Medicine (United States)), Amanda M. Prechtl(Precision for Medicine (United States))
Cited by 8
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903